Zacks Analyst Blog Highlights: Laboratory Corporation of America Holdings, Genzyme, The Kroger Company, Wal-Mart Stores and Costco Wholesale - Press Releases

For Immediate Release

Chicago, IL – September 14, 2010 – Zacks.com Analyst Blog features: Laboratory Corporation of America Holdings (LH), Genzyme Corporation (GENZ), The Kroger Company (KR), Wal-Mart Stores Inc. (WMT) and Costco Wholesale Corporation (COST ).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Monday's Analyst Blog:

LabCorp to Acquire Genzyme

Leading diagnostic company Laboratory Corporation of America Holdings (LH) has decided to acquire Genzyme Genetics, a unit of Genzyme Corporation (GENZ) for $925 million. This asset was put up for sale in May 2010 to increase shareholder value. Genzyme's plan to divest the other two units – Diagnostic Products and Pharmaceutical Intermediates – is still on track.

Genzyme Genetics, which provides complex reproductive and oncology testing services, performs more than 1.5 million tests annually and recorded $371 million of revenue in 2009. Subsequent to this transaction, LabCorp will be able to strengthen its esoteric testing business. The transaction, subject to approvals, is expected to close by the year-end.

During the second quarter conference call, LabCorp provided an update regarding the acquisition market. The company found the acquisition market to be attractive (as valuations have declined) with a number of opportunities existing in the esoteric testing franchise.

Esoteric testing accounted for 36% of LabCorp's revenues in 2009, which the company plans to increase to 40% in the next 3-5 years. During the second quarter, esoteric volume increased 4.9% although revenue per requisition was up marginally (0.2%). The company has launched several new tests in the field of esoteric testing which includes BRAF gene mutation detection, EGFR mutation analysis for non-small cell lung cancer, HERmark for breast cancer among others. We believe, with meaningful acquisitions, LabCorp is on its way to achieving a higher volume in the esoteric testing market.

Earnings Preview: Kroger

The Kroger Company (KR), one of the largest US grocery retailers, is scheduled to report its second-quarter 2010 financial results on Tuesday, September 14, 2010. The current Zacks Consensus Estimate for the quarter is 36 cents a share.

First-Quarter 2010, a Synopsis

Kroger posted first-quarter 2010 results that topped the Zacks expectations. Quarterly earnings of 58 cents a share outpaced the Zacks Consensus Estimate of 54 cents but dropped 12.1% from 66 cents delivered in the prior-year quarter. Total revenue for the quarter was $24,764.1 million (including fuel center sales), up 8.7% from the year-ago quarter.

Excluding fuel center sales, total revenue climbed 3.1%; comparable supermarket sales jumped 2.7% to $20,376 million, whereas identical supermarket sales (stores that are open without expansion or relocation for five full quarters) rose 2.4% to $19,781.8 million.

Kroger, a Cincinnati-based company, reaffirmed its fiscal year 2010 earnings guidance range of $1.60 to $1.80 per share at its last earnings call.

Second-Quarter 2010 Consensus

Analysts surveyed by Zacks expect Kroger to post second-quarter 2010 earnings of 36 cents a share. The current Zacks Consensus Estimate represents a year-over-year decline of 7.7%. The estimates in the current Zacks Consensus for the quarter range from a low of 32 cents to a high of 40 cents.

The current Zacks Consensus Estimate has remained stagnant over the last 30 days; with only 2 out of 17 analysts covering the stock revising their estimates downward. In the last 7 days too, only one analyst has lowered the forecast, while the others have kept their estimates unaltered, leaving the consensus unchanged.

Earnings Surprise History

With respect to earnings surprises, Kroger has veered from the Zacks Consensus Estimate over the last four quarters from negative 25% to positive 14.7%. The average remained at negative 3.6%. This suggests that Kroger has underperformed the Zacks Consensus Estimate by an average of 3.6% in the last four quarters.

Kroger in Neutral Lane

We believe that the company's dominant position enables it to sustain top line growth, expand store base and boost market share. Kroger's customer-centric business model provides a strong value proposition to consumers. It is well positioned to continue its growth momentum primarily through identical supermarket sales growth.

However, the intensifying price war among grocery stores to lure price-focused consumers has compelled Kroger to cut prices, hurting its sales and margins. Consumers are trading down to cheaper substitute brands and shopping for groceries at low-price leaders such as Wal-Mart Stores Inc. (WMT) and Costco Wholesale Corporation (COST ).

Kroger currently operates 2,470 supermarkets and multi-department stores in 31 states under approximately 24 local banners. It maintains a Zacks #3 Rank (Hold), and is in line with our long-term Neutral recommendation for the stock.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com

 

 


 
COSTCO WHOLE CP (COST): Free Stock Analysis Report
 
GENZYME-GENERAL (GENZ): Free Stock Analysis Report
 
KROGER CO (KR): Free Stock Analysis Report
 
LABORATORY CP (LH): Free Stock Analysis Report
 
WAL-MART STORES (WMT): Free Stock Analysis Report
 
Zacks Investment Research
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechnologyConsumer StaplesFood RetailHealth CareHealth Care ServicesHypermarkets & Super Centers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!